Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luke Maese

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Future Oncology (London, England)|January 13, 2018
The evidence for expanded genetic testing for pediatric patients with cancerLuke Maese, Joshua D Schiffman
Frontiers in Pediatrics|July 18, 2022
Current Use of Asparaginase in Acute Lymphoblastic Leukemia/Lymphoblastic LymphomaLuke Maese, Rachel E Rau
Best Practice & Research. Clinical Haematology|November 30, 2019
Can Ph-like ALL be effectively targeted?Luke Maese, Elizabeth A Raetz
Best Practice & Research. Clinical Haematology|October 21, 2017
How is the Ph-like signature being incorporated into ALL therapy?Luke Maese, Sarah K Tasian, Elizabeth A Raetz
Blood and Lymphatic Cancer : Targets and Therapy|April 28, 2021
Clinical Utility of Pegaspargase in Children, Adolescents and Young Adult Patients with Acute Lymphoblastic Leukemia: A ReviewCynthia Bender, Luke Maese, Maria Carter-Febres, et al.
Fetal and Pediatric Pathology|January 20, 2017
Acute Leukemia and Concurrent Mediastinal Germ Cell Tumor: Case Report and Literature ReviewLuke Maese, K David Li, Xinjie Xu, et al.
Journal of Medical Economics|May 21, 2026
Economic burden associated with switching from frontline pegaspargase or calaspargase pegol to second-line recombinant <i>Erwinia</i> in pediatrics and adolescents/young adults with acute lymphoblastic leukemiaMeghan McCormick, Tina Gu, Tarun Bhagnani, et al.
Journal of Pediatric Hematology/Oncology|January 15, 2021
Two Clonally Distinct B-Cell Lymphomas Reveal the Diagnosis of XLP1 in a Male Child and His Asymptomatic Male Relatives: Case Report and Review of the LiteratureFiorella Iglesias Cardenas, Archana M Agarwal, Jennie Vagher, et al.
Pediatric Blood & Cancer|June 9, 2021
Can recombinant technology address asparaginase Erwinia chrysanthemi shortages?Luke Maese, Carmelo Rizzari, Russell Coleman, et al.
Pediatric Blood & Cancer|December 14, 2020
Bone marrow necrosis in pediatric malignancies: 10-Year retrospective review and review of literatureMichell Lozano-Chinga, Lauren Draper, Tracy I George, et al.
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Future Oncology (London, England)|January 13, 2018
The evidence for expanded genetic testing for pediatric patients with cancerLuke Maese, Joshua D Schiffman
Frontiers in Pediatrics|July 18, 2022
Current Use of Asparaginase in Acute Lymphoblastic Leukemia/Lymphoblastic LymphomaLuke Maese, Rachel E Rau
Best Practice & Research. Clinical Haematology|November 30, 2019
Can Ph-like ALL be effectively targeted?Luke Maese, Elizabeth A Raetz
Best Practice & Research. Clinical Haematology|October 21, 2017
How is the Ph-like signature being incorporated into ALL therapy?Luke Maese, Sarah K Tasian, Elizabeth A Raetz
Blood and Lymphatic Cancer : Targets and Therapy|April 28, 2021
Clinical Utility of Pegaspargase in Children, Adolescents and Young Adult Patients with Acute Lymphoblastic Leukemia: A ReviewCynthia Bender, Luke Maese, Maria Carter-Febres, et al.
Fetal and Pediatric Pathology|January 20, 2017
Acute Leukemia and Concurrent Mediastinal Germ Cell Tumor: Case Report and Literature ReviewLuke Maese, K David Li, Xinjie Xu, et al.
Journal of Medical Economics|May 21, 2026
Economic burden associated with switching from frontline pegaspargase or calaspargase pegol to second-line recombinant <i>Erwinia</i> in pediatrics and adolescents/young adults with acute lymphoblastic leukemiaMeghan McCormick, Tina Gu, Tarun Bhagnani, et al.
Journal of Pediatric Hematology/Oncology|January 15, 2021
Two Clonally Distinct B-Cell Lymphomas Reveal the Diagnosis of XLP1 in a Male Child and His Asymptomatic Male Relatives: Case Report and Review of the LiteratureFiorella Iglesias Cardenas, Archana M Agarwal, Jennie Vagher, et al.
Pediatric Blood & Cancer|June 9, 2021
Can recombinant technology address asparaginase Erwinia chrysanthemi shortages?Luke Maese, Carmelo Rizzari, Russell Coleman, et al.
Pediatric Blood & Cancer|December 14, 2020
Bone marrow necrosis in pediatric malignancies: 10-Year retrospective review and review of literatureMichell Lozano-Chinga, Lauren Draper, Tracy I George, et al.
Pageof 4